Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kengo Azushima

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|June 15, 2017
An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac AbnormalitiesShintaro Minegishi, Tomoaki Ishigami, Hisho Kawamura, et al.
International Journal of Molecular Sciences|June 13, 2017
Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO MiceTabito Kino, Tomoaki Ishigami, Tsumugi Murata, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|December 13, 2016
Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney diseaseKazushi Uneda, Kouichi Tamura, Hiromichi Wakui, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 22, 2021
Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trialYuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 22, 2017
Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney diseaseKengo Azushima, Hiromichi Wakui, Kazushi Uneda, et al.
Diabetes|August 2, 2018
Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic NephropathySusan B Gurley, Sujoy Ghosh, Stacy A Johnson, et al.
American Journal of Cardiovascular Disease|January 19, 2012
Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney diseaseKouichi Tamura, Tomohiko Kanaoka, Masato Ohsawa, et al.
Plos One|October 17, 2013
Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesityKengo Azushima, Kouichi Tamura, Hiromichi Wakui, et al.
Cardiovascular Research|November 6, 2013
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertensionHiromichi Wakui, Toru Dejima, Kouichi Tamura, et al.
Journal of Pharmacological Sciences|July 23, 2021
Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patientsYuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|June 15, 2017
An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac AbnormalitiesShintaro Minegishi, Tomoaki Ishigami, Hisho Kawamura, et al.
International Journal of Molecular Sciences|June 13, 2017
Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO MiceTabito Kino, Tomoaki Ishigami, Tsumugi Murata, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|December 13, 2016
Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney diseaseKazushi Uneda, Kouichi Tamura, Hiromichi Wakui, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 22, 2021
Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trialYuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 22, 2017
Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney diseaseKengo Azushima, Hiromichi Wakui, Kazushi Uneda, et al.
Diabetes|August 2, 2018
Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic NephropathySusan B Gurley, Sujoy Ghosh, Stacy A Johnson, et al.
American Journal of Cardiovascular Disease|January 19, 2012
Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney diseaseKouichi Tamura, Tomohiko Kanaoka, Masato Ohsawa, et al.
Plos One|October 17, 2013
Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesityKengo Azushima, Kouichi Tamura, Hiromichi Wakui, et al.
Cardiovascular Research|November 6, 2013
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertensionHiromichi Wakui, Toru Dejima, Kouichi Tamura, et al.
Journal of Pharmacological Sciences|July 23, 2021
Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patientsYuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, et al.
Pageof 11